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Abstract The 5P-flanking region of human Q-glutamylcysteine
synthetase-heavy subunit (Q-GCS-HS) was characterised by
creating a series of chloramphenicol acetyl transferase (CAT)
reporter deletion constructs. Analysis of various deleted CAT
constructs revealed that a putative AP-1 consensus sequence is
required to direct the constitutive and oxidant-mediated promo-
ter activity. Gel mobility shift and mutation analysis of the
sequence (3269 to 3263 bp), showed binding of AP-1 is involved
in the oxidant-mediated regulation of Q-GCS-HS promoter
activity.
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1. Introduction
The tripeptide glutathione (GSH) or L-Q-glutamyl-cysteinyl-
glycine is a ubiquitous cellular non-protein sulfhydryl which
has an important role in maintaining intracellular redox bal-
ance and is involved in the detoxi¢cation of peroxides, free
radicals, heavy metals and xenobiotics [1]. Decreased levels of
GSH in epithelial lining £uid (ELF) have been demonstrated
in various in£ammatory diseases such as HIV infection [2],
idiopathic pulmonary ¢brosis [3], adult respiratory distress
syndrome [4] and cystic ¢brosis [5].
Glutathione is synthesised by two enzymes, Q-glutamylcys-
teine synthetase (Q-GCS) which is the rate limiting enzyme,
and glutathione synthetase [6]. The Q-GCS holoenzyme exists
as a dimer, composed of heavy (Q-GCS-HS; 73 kDa) and light
(Q-GCS-LS; 28 kDa) subunits [7]. The heavy subunit possesses
all of the catalytic activity [8].
The 5P-£anking region of the human Q-GCS-HS has been
cloned and sequenced. Various putative transcription factors
such as AP-1 (c-fos/c-jun)/TRE, AP-1-like, NF-UB, AP-2, SP-
1, metal response element (MRE) and antioxidant response
(ARE)/electrophile response (EpRE) elements have been iden-
ti¢ed [9^11]. Recently we have shown that exposure to mena-
dione (MQ), hydrogen peroxide (H2O2) or cigarette smoke
induced chloramphenicol acetyl transferase (CAT) activity in
human alveolar epithelial cells (A549) transfected with 31050
to +82 bp of the 5P-£anking region of the Q-GCS-HS pro-
moter, subcloned into a CAT reporter system [12,13]. We
and others have recently shown that AP-1 binding may be
required for the transcriptional activation of Q-GCS-HS in
response to cigarette smoke, cisplatin, okadaic acid or tumour
necrosis factor (TNF)-K [10,12,14^16]. Both c-jun, and Jun B
can participate in transcriptional transactivation of ARE/
EpRE elements in addition to TRE/AP-1 activity [17]. Expres-
sion of Q-GCS has clearly been shown to be regulated by the
AP-1 transcription factor in yeasts [18]. Deletion and muta-
tional analysis of the Q-GCS-HS promoter (33802: +465),
cloned into a reporter system has also revealed that a func-
tional distal TRE/ARE element, located between 33802 and
32752 bp, is important for the constitutive and L-naptho£a-
vone inducible expression [11]. However, there is no informa-
tion so far available on the characteristics of the Q-GCS-HS
promoter region under conditions of oxidative stress.
Menadione (2-methyl-1,4-napthoquinone, MQ) is a quinone
which imposes oxidative stress by generating reactive oxygen
species (ROS) due to redox cycling. Recent evidence indicates
that quinone compounds and hydrogen peroxide can induce Q-
GSH-HS in various cell lines [13,19,20]. However, the exact
molecular mechanism of induction of Q-GCS-HS is not
known. Therefore, in the present study, we have utilised a
deletion analysis to identify the sequences that modulate the
constitutive and oxidant-induced expression of the human Q-
GCS-HS gene 5P-£anking region.
2. Materials and methods
Unless otherwise stated, all of the biochemical reagents used in this
study were purchased from the Sigma Chemical Co, Poole, England;
cell culture media and molecular biology reagents from GIBCO-BRL,
Paisley, Scotland.
2.1. Promoter deletion constructs
The Q-GCS-HS promoter was isolated by PCR from human ge-
nomic DNA using the upstream oligonucleotide 5P-(+82)GGCGA-
CATCCAATATGAAGGCTGTG-3P and downstream oligonucleo-
tide 5P-(31050)TTCCTACTTGTGACCAAAACCTGCG-3P. The
resulting promoter fragment (31050 to +82 bp) was con¢rmed by
DNA-sequencing. The promoter fragment was cloned into pCRII
cloning vector (Invitrogen, USA) and a HindIII and SphI fragment
(1138 bp) containing the promoter was isolated and subcloned into
polylinker of the promoterless plasmid pCAT Basic vector (Promega,
USA). This construct was denoted pCBGCS. Deletion fragments of
the Q-GCS-HS promoter were generated using KpnI restriction site
present within the Q-GCS-HS promoter which resulted in a short frag-
ment containing the ARE (31050 to 3818 bp) (pCBGCSA) and a
large fragment (3817 to +82 bp) (pCBGCSvK) containing AP-1 and
AP-1-like sites. Further deletion of Q-GCS-HS promoter was carried
out using a BalI restriction site present within the pCBGCSvK, which
resulted in a fragment (3511 to +82 bp) (pCBGCSvB) containing one
of each of the AP-1 and AP-1-like sites. pCBGCSvB was subjected to
digestion with DraII to generate a deletion mutant, pCBGCSvD
(3305 to +82 bp) containing AP-1 at 3269 to 3263 bp, CAAT
and TATA boxes. To create a further deletion mutant lacking the
putative proximal AP-1 site, pCBGCSvK was digested using NsiI
which produced a large fragment 3817 to 3204 bp and a small frag-
ment 3201 to +82 bp. The small fragment was denoted by
pCBGCSvN. All of the fragments were subcloned into a pCAT Basic
vector.
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2.2. A549 epithelial cells
The type II alveolar epithelial cell line, A549 (ECACC No.
86012804), which was mycoplasma free, was maintained in continuous
culture at 37‡C, 5% CO2 in Dulbecco’s modi¢ed minimum essential
medium (DMEM, GIBCO) containing penicillin/streptomycin mix-
ture, L-glutamine, sodium bicarbonate, and 10% foetal bovine serum
(FBS) (GIBCO, Paisley, Scotland).
2.3. Transient transfection and CAT assay
A549 cells (0.8U106) per well were seeded into 6-well tissue culture
plates and cultured at 37‡C until 70^80% con£uent. Plasmid DNA
transfections were performed using lipofecAMINE reagent (GIBCO).
After H2O2 (100 WM) or MQ (100 WM) treatments, cell extracts were
prepared and assayed for protein content using BCA reagent (Pierce,
Rockford, IL, USA). Chloramphenicol acetyl transferase (CAT) ac-
tivity was quantitated by the CAT enzyme-linked immunosorbent
assay (ELISA). The L-galactosidase expression plasmid (PSV-Gal,
Promega) was co-transfected as an internal control to normalise trans-
fection e⁄ciency. In all transfection experiments, pCAT-Basic, pCAT-
Control were used as negative and positive controls, respectively.
2.4. Preparation of nuclear extracts and the electrophoretic
mobility shift assay (EMSA)
Nuclear extracts were prepared by the method of Staal et al. [21].
The oligonucleotides for the AP-1 site (3269 to 3263 bp) present in
native Q-GCS-HS-AP-1 (5P-GAGTTCGTCATTGATTCAAATAAT-
3P, 3P-CTCAAGCAGTAACTAAGTTTATTA-5P) and its mutant
consensus sequences (5P-GAGTTCGTCATGATCCTGAATAAT-3P,
3P-CTCAAGCAGTACTAGGACTTATTA-5P) were synthesised by
MWG-BIOTECH GMbH, Ebersberg, Germany. The consensus se-
quence of AP-1 is indicated by bold letters and its mutated sequence
by the underlined letters. Both the oligonucleotides were end-labelled
with (Q-32P)-ATP using T4 polynucleotide kinase and (Q-32P)-ATP,
according to the manufacturer’s instructions (Promega). Binding re-
actions were carried out using 25 Wg of nuclear extract protein, 0.25
mg/ml poly(dI-dC)Wpoly(dI-dC), binding bu¡er (Promega) and Q-GCS-
HS AP-1 and its mutant labelled probes as described above. Incuba-
tion was carried out at room temperature for 20 min. The protein-
DNA complexes were resolved on non-denaturating 5% polyacryl-
amide gels at 100 mV for 3^4 h. The gels were then vacuum dried
and autoradiographed overnight with an intensifying screen at 380‡C.
For the competition experiment, a 100-fold molar excess of unlabelled
AP-1 (5P-CGCTTGATGAGTCAGCCGGAA-3P, 3P-CGCAACTAC-
TCAGTCGGCCTT-5P) and NF-UB (5P-AGTTGAGGGGACTTT-
CCCAGGCP-3, 3P-TCAACTCCCCTGAAAGGGTCCG-5P) oligonu-
cleotides (Promega) were incubated in the reaction mixture.
2.5. Statistical analysis
Results were expressed as mean þ S.E.M. Di¡erences between val-
ues were compared by Duncan’s multiple range test.
3. Results
3.1. Regulation of constitutive expression of the
Q-GCS-HS 5P-£anking region
We examined the involvement of various transcription fac-
tor binding sites in the regulation of constitutive expression of
Q-GCS-HS 5P-£anking region. Various deletion strategies de-
scribed above were used to produce several deletion mutants,
which were then cloned into the upstream region of the CAT
reporter plasmid (Fig. 1A). Transcriptional activity of the
reporter constructs in A549 epithelial cells was examined.
The transcriptional activity of the longest fragment, spanning
31050 to +82 bp of the Q-GCS-HS gene (pCBGCS) was taken
as 100% (Fig. 1B). Deletion of the fragment from 31050 to
3818 bp did not increase the constitutive transcriptional ac-
tivity of pCBGCSvK (97 þ 20%, n = 4), compared to that of
pCBGCS. This deleted fragment contained multiple putative
cis-acting DNA elements including an ARE and an AP-2 site.
However, a further deletion from 3817 to 3511 bp, which
contained an EpRE and AP-1-like sites, increased the CAT
activity of pCBGCSvB to 152 þ 22%, n = 4, P6 0.01, com-
pared to that of pCBGCS. The increased activity was not
a¡ected by deletion of fragment from 3511 to 3305 bp,
which contained an AP-1-like site pCBGCSvD 147 þ 17%,
n = 4, P6 0.01, compared to pCBGCS. However, the activity
was signi¢cantly decreased after deletion of the proximal pu-
tative AP-1 site present between 3269 to 3263 bp,
pCBGCSvN 26 þ 10%, n = 4, P6 0.001, compared to
pCBGCS (Fig. 1B).
3.2. Regulation of oxidant-induced expression of the
Q-GCS-HS 5P-£anking region
We have previously demonstrated a signi¢cant increase in
the CAT activity in A549 epithelial cells transfected with the
full promoter and pCBGCSvK, linked to the CAT reporter
system (pCBGCS) after exposure to H2O2 (100 WM) and MQ
(100 WM) [13]. In the present study, we made further deletion
constructs of Q-GCS-HS 5P-£anking region and studied the
e¡ects of H2O2 (100 WM) and MQ (100 WM) on the regulation
of CAT activity in A549 epithelial cells (Fig. 1A, B). CAT
activity increased signi¢cantly in pCBGCSvB (H2O2
325 þ 31%, MQ 277 þ 38%, P6 0.001, n = 4), compared to
that of pCBGCS in response to the oxidants. The CAT activ-
ity was more pronounced in pCBGCSvD (H2O2 342 þ 33%,
MQ 293 þ 35%, P6 0.001, n = 4) compared to pCBGCS.
However, the CAT activity was signi¢cantly reduced in
pCBGCSvN (H2O2 33 þ 9%, MQ 22 þ 11%, P6 0.001,
n = 4), compared to pCBGCS.
3.3. E¡ect of H2O2 and MQ on the activation of proximal
AP-1
The use of successive deletion constructs showed that se-
quence from 3303 to 3201 bp, which contained a putative
AP-1 transcription factor binding site, may be required for the
transcriptional regulation of Q-GCS-HS in response to oxi-
dants. Therefore, to determine if the increase in the
pCBGCSvD CAT activity was associated with the activation
of the transcription factor AP-1 DNA binding (3269 to 3263
bp), we investigated the e¡ects of H2O2 and MQ on the prox-
imal Q-GCS-HS AP-1, oligonucleotide DNA binding in A549
alveolar epithelial cells by EMSA. We showed an increase in
the Q-GCS-HS AP-1 binding activity in response to H2O2 and
MQ (P6 0.001) (Fig. 2A, B). The binding was not signi¢-
cantly changed when 50-fold excess mutant Q-GCS-HS AP-1
was used in the binding reaction. The speci¢city of the AP-1
binding was checked using 100-fold excess unlabelled AP-1
oligonucleotides (Promega) and non-speci¢c oligonucleotides
for NF-UB. The band obtained by oxidant treatments was
completely abolished using labelled AP-1 oligonucleotides
(Promega), whereas non-competitor NF-UB oligonucleotides
did not interfere in the DNA protein binding con¢rming the
involvement of AP-1.
4. Discussion
The 5P-£anking nucleotide sequence of the human Q-GCS-
HS gene contains ARE, NF-UB, AP-1/TRE, AP-1-like, and
AP-2 binding sites [9^11]. We have previously demonstrated
that H2O2 and MQ induced transcriptional activity of the 5P-
£anking sequence of the Q-GCS-HS using a CAT reporter
system [12,13]. However, the critical transcription factor(s)
involved in the regulation of Q-GCS-HS promoter is not
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known so far. In this study, using deletion constructs for Q-
GCS-HS 5P-£anking region, we showed that the 3511 to +82
bp is involved in the constitutive expression of the Q-GCS-HS
promoter activity. Furthermore, deletions of the 5P-£anking
region revealed that a proximal sequence of the Q-GCS-HS
gene, speci¢cally 3303 to 3201 bp, was critical in the tran-
scriptional up-regulation in oxidant-exposed alveolar epithe-
lial cells. This is con¢rmed by deletion of fragment containing
the proximal AP-1 site, which produced a dramatic fall in the
promoter activity, and the abolition of the oxidant-mediated
e¡ect. Thus the 5P-£anking region of the Q-GCS-HS contains a
putative AP-1 binding site at 3269 to 3263, which appears to
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Fig. 1. Constitutive and inducible regulation of the Q-GCS-HS 5P-£anking region in a CAT reporter system. The 5P-£anking successive deletion
sequence of the Q-GCS-HS gene from oligonucleotides 31050, 3818, 3511, 3305, 3201 to +82 bp were cloned into pCAT-Basic and co-trans-
fected into A549 alveolar epithelial cells along with the control plasmid PSV-L-Gal. Panel A shows the relative positions of the cis-acting DNA
elements and a restriction map of the promoter region cloned in pCRII vector. The numbers in the ¢gure represent the nucleotide positions
from the transcriptional start site of the Q-GCS-HS gene, which is indicated by the bent arrow on the right. The dotted line on the left indicates
an additional 50 bp from multiple cloning sites of the pCRII vector. The structure of the Q-GCS-HS CAT plasmids are shown below on the
right. Deletion mutants were ligated to upstream of the CAT gene in pCAT Basic vector (pCB) and its constitutive transcriptional CAT activ-
ity was measured 36^48 h post-transfection. Various deleted constructs were transfected into A549 cells and exposed to H2O2 (100 WM) and
MQ (100 WM). After 24 h incubation, the cells were harvested and assayed for CAT activity. Panel B: Transcriptional activity among di¡erent
constructs was standardised by the amount of CAT activity relative to L-Gal activity. The results are shown as percentages of the CAT concen-
tration compared to that of pCBGCS. Each histogram represents the mean and the bars the S.E.M. of four independent transfections, each
performed in duplicate with the activity pCBGCS set at 100%. **P6 0.01, ***P6 0.001, compared to pCBGCS.
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be involved in the regulation of Q-GCS-HS expression in re-
sponse to oxidative stress.
Yao and co-workers previously showed that the nuclear
factors of the Jun family bind to this AP-1 site [10]. They
also showed that expression of the Q-GCS-HS gene increased
in cisplatin-resistant human ovarian cells. Similarly, Tomonari
and colleagues [14] showed that an AP-1 regulatory site
present in the proximal 5P-£anking sequence of the human
Q-GCS-HS was involved in cisplatin-induced transcriptional
up-regulation in a SBC-3 cancer cell line. These results are
supported by the recent demonstration of the participation
of AP-1 in the regulation of glutathione metabolism in human
hepatoma (HepG2) cells [15]. All of these studies used cispla-
tin to assess the regulation of the Q-GCS-HS promoter. How-
ever, our interest is focused on the role of the oxidant/anti-
oxidant imbalance, in particular GSH and its redox system,
which is known to be altered in various in£ammatory lung
diseases [3^5]. Therefore, in this study using H2O2 and MQ,
we were able to show activation of an AP-1 present in
pCBGCSvD in human alveolar epithelial cells. Thus our
data suggest that a putative AP-1 site, present in the proximal
region of the 5P-£anking region, is involved in the regulation
of Q-GCS-HS expression in response to oxidants in alveolar
epithelial cells. Further analysis of Q-GCS-HS AP-1 binding in
response to oxidants by the gel shift assay revealed that AP-1
is speci¢cally able to bind with the proximal AP-1 site present
in the Q-GCS-HS promoter. This is con¢rmed by mutant Q-
GCS-HS AP-1, which did not inhibit AP-1 binding in A549
cells in response to oxidants, whereas the Q-GCS-HS AP-1
binding was completely abolished by commercially available
AP-1 oligonucleotides. Our data are in agreement with the
recent observation of Morale et al. [16] who suggested that
an AP-1 binding site may be required for the induction of Q-
GCS-HS gene by TNF-K in HepG2 cells. However, Mulcahy
and co-workers [11] recently reported that an ARE, present at
33147 to 33137 bp played a critical role in the transcriptional
up-regulation of the Q-GCS-HS gene by L-naptho£avone in
HepG2 cells. The apparently con£icting results of that study
to those of our own may be a re£ection of the fact that multi-
ple putative transcription factors are involved in response to
di¡erent stimuli in di¡erent cells.
In conclusion, we have shown that the proximal 5P-£anking
sequence of the Q-GCS-HS gene, in particular from 3303
to3201 bp, is involved in oxidant-induced transcriptional
up-regulation in alveolar epithelial cells. Studies using the
gel shift assay of the proximal Q-GCS-HS AP-1 oligonucleo-
tides showed that the AP-1 site present in the 3269 to 3263
bp is involved in the transcriptional up-regulation of Q-GCS-
HS gene under oxidative stress.
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Fig. 2. E¡ects of H2O2 (100 WM) and MQ (100 WM) exposure on the induction of Q-GCS-HS AP-1 binding activities in A549 cells. A: Nuclear
extracts were prepared and 25 Wg of protein was analysed by the electrophoretic mobility shift assay, performed in triplicate, using 32P-labelled
proximal Q-GCS-HS AP-1 sequence as probe. Cold mutant Q-GCS-HS AP-1 and AP-1 (Promega) were used as competitors and NF-UB oligonu-
cleotide was used as non-competitor. The DNA-protein complexes formed are indicated (arrow). Nuclear extracts from HeLa cells were used as
a positive control (data not shown). B: The gel was scanned using a GS 2600 gel documentation system, UVP (Orme Technologies, Cambridge,
England). The numeric estimates of DNA binding levels were compared with the control value set at 100%. Data are expressed as mean þ
S.E.M. of relative intensity of bands of three experiments. ***P6 0.001 compared to control.
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